Your browser version may not work well with NCBI's Web applications. More information here...
1: Breast Cancer Res. 2004;6(4):165-9. Epub 2004 Jun 16.
Related Articles, Links
Click here to read Click here to read
Clinical trials update of the European Organization for Research and Treatment of Cancer Breast Cancer Group.

Rutgers EJ, Meijnen P, Bonnefoi H; European Organization for Research and Treatment of Cancer Breast Cancer Group.

Department of Surgery, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. e.rutgers@nki.nl

The present clinical trial update consists of a review of two of eight current studies (the 10981-22023 AMAROS trial and the 10994 p53 trial) of the European Organization for Research and Treatment of Cancer Breast Cancer Group, as well as a preview of the MIND-ACT trial. The AMAROS trial is designed to prove equivalent local/regional control for patients with proven axillary lymph node metastasis by sentinel node biopsy if treated with axillary radiotherapy instead of axillary lymph node dissection, with reduced morbidity. The p53 trial started to assess the potential predictive value of p53 using a functional assay in yeast in patients with locally advanced/inflammatory or large operable breast cancer prospectively randomised to a taxane regimen versus a nontaxane regimen.

Publication Types:
PMID: 15217489 [PubMed - indexed for MEDLINE]

PMCID: PMC468675